1. Théron A, Maumus M, Bony-Garayt C, Sirvent N, Biron-Andreani C, Jorgensen C, et al. Mesenchymal Stromal Cells Prevent Blood-induced Degeneration of Chondrocytes in a New Model of Murine Hemarthrosis. Hemasphere. 2023;7:e924. [
DOI] [
PMID] [
PMCID]
2. Mansouritorghabeh H. Clinical and laboratory approaches to hemophilia a. Iran J Med Sci. 2015;40:194-205. [
PMID] [
PMCID]
3. Hart DP, Matino D, Astermark J, Dolan G, d'Oiron R, Hermans C, et al. International consensus recommendations on the management of people with haemophilia B. Therapeutic advances in hematology. 2022 Apr;13:20406207221085202. [
DOI] [
PMID] [
PMCID]
4. Shih MY, Wang JD, Yin JD, Tsan YT, Chan WC. Differences in Major Bleeding Events Between Patients With Severe Hemophilia A and Hemophilia B: A Nationwide, Population-Based Cohort Study. Clin Appl Thromb Hemost. 2019;25:1076029619888023. [
DOI] [
PMID] [
PMCID]
5. Loscalzo J, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL. Harrison's principles of internal medicine, 19e. Mcgraw-hill, New York; 2020. [
URL]
6. Centers for Disease Control and Prevention. Treatment of Hemophilia. 2023. Accessed July 12, 2023. https://www.cdc.gov/ncbddd/hemophilia/treatment.html. [
URL]
7. Srivastava A, Santagostino E, Dougall A, Kitchen S, Sutherland M, Pipe SW, et al. WFH guidelines for the management of hemophilia. Haemophilia. 2020 Aug;26:1-58. [
DOI] [
PMID]
8. Nathwani AC. Gene therapy for hemophilia. Hematology Am Soc Hematol Educ Program. 2022;2022:569-78. [
DOI] [
PMID] [
PMCID]
9. Chowdary P. Anti-tissue factor pathway inhibitor (TFPI) therapy: a novel approach to the treatment of haemophilia. Int J Hematol. 2020;111:42-50. [
DOI] [
PMID]
10. Plug I, Peters M, Mauser-Bunschoten EP, et al. Social participation of patients with hemophilia in the Netherlands. Blood. 2008;111:1811-5. [
DOI] [
PMID]
11. Arya S, Siad FM, Wilton P, Page D, Boma-Fischer L, Floros G, et al. Invisible bleeds: Lived experiences and barriers to care for men with hemophilia. Journal of Thrombosis and Haemostasis. 2022 Feb 1;20(2):296-306. [
DOI] [
PMID]
12. Hobson J, Smedley J, editors. Fitness for Work: The Medical Aspects. Oxford University Press, USA; 2019. [
DOI]
13. Chu WM, Ho HE, Wang JD, Chan WC, Liou YS, Ho WC, et al. Risk of major comorbidities among workers with hemophilia: A 14-year population-based study. Medicine (Baltimore). 2018 Feb;97(6):e9803. [
DOI] [
PMID] [
]
14. Maffet M, Roton J Jr. Hemophilia in Sports: A Case Report and Prophylactic Protocol. J Athl Train. 2017 Jan;52(1):65-70. [
DOI] [
PMID] [
PMCID]
15. duTreil S. Physical and psychosocial challenges in adult hemophilia patients with inhibitors. J Blood Med. 2014 Jul 22;5:115-22. [
DOI] [
PMID] [
PMCID]
16. Adekola B, Adekola HA. A mini review on the impact of workplace response on employee health and well-being during viral disease outbreaks in three multinational organizations: a personnel psychology viewpoint. Health Science Monitor. 2024;3(3):226-22. [
DOI]